Strategy
MSTR
MARA Holdings
MARA
NVIDIA
NVDA
Tesla
TSLA
Coinbase
COIN
US Stock MarketDetailed Quotes
IMNM Immunome
- 9.400
- +0.510+5.74%
Close Feb 28 16:00 ET
- 9.400
- 0.0000.00%
Post 20:01 ET
768.65MMarket Cap-1.18P/E (TTM)
9.440High8.550Low893.84KVolume8.700Open8.890Pre Close8.22MTurnover1.44%Turnover RatioLossP/E (Static)81.77MShares30.95852wk High3.58P/B584.78MFloat Cap8.55052wk Low--Dividend TTM62.21MShs Float63.780Historical High--Div YieldTTM10.01%Amplitude2.090Historical Low9.197Avg Price1Lot Size
About Immunome Company
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
Company Profile
SymbolIMNM
Company NameImmunome
Listing DateOct 2, 2020
Issue Price12.00
Founded2006
CEODr. Clay B. Siegall,PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address18702 North Creek Parkway,Suite 100
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-939-7410
Websitehttp://www.immunome.com
Company Executives
- Name
- Position
- Salary
- Dr. Clay B. Siegall,PhD
- Chief Executive Officer, President and Chairman of the Board
- 14.87M
- Max Rosett
- Principal Accounting Officer, Executive Vice President, Operations and Interim Chief Financial Officer
- --
- Dr. Jack Higgins, PhD
- Chief Scientific Officer
- 1.84M
- Kinney Horn
- Chief Business Officer
- --
- Bob Lechleider
- Chief Medical Officer
- 2.92M
- Sandra G. Stoneman
- Chief Legal Officer and General Counsel
- --
- Dr. Bruce Turner, M.D.,PhD
- Chief Strategy Officer
- --
- Dr. Sandra M. Swain, M.D.
- Director
- --
- Philip Wagenheim
- Director
- 59.23K
- Carol A. Schafer
- Director
- --
- Jean-Jacques Bienaime
- Independent Director
- 287.93K
- Isaac Barchas, J.D.
- Lead Independent Director
- 296.59K
- James P. Boylan, M.B.A.
- Independent Director
- 294.75K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.